Jul

4

2022

What is the prevalence of antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?

By William Aird

Between 20% and 30% of patients with SLE have persistent moderate-to-high-risk antiphospholipid-antibody profiles that are associated with an increased risk of clinical sequelae.

Learn more here.